MX2017014319A - Sal sodica de inhibidor de transportador de acido urico y su forma cristalina. - Google Patents
Sal sodica de inhibidor de transportador de acido urico y su forma cristalina.Info
- Publication number
- MX2017014319A MX2017014319A MX2017014319A MX2017014319A MX2017014319A MX 2017014319 A MX2017014319 A MX 2017014319A MX 2017014319 A MX2017014319 A MX 2017014319A MX 2017014319 A MX2017014319 A MX 2017014319A MX 2017014319 A MX2017014319 A MX 2017014319A
- Authority
- MX
- Mexico
- Prior art keywords
- sodium salt
- uric acid
- acid transporter
- transporter inhibitor
- crystal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
La presente invención se relaciona con una sal sódica de un inhibidor de transportador de ácido úrico y la forma cristalina del mismo. En particular, la presente invención se relaciona con la sal sódica de un inhibidor de transportador de ácido úrico (URAT1), el cristal tipo I y el método de preparación del mismo. La presente invención se relaciona con formato de 1-((6-bromo-quinolin-4-il)tio)ciclobutil de sodio (el compuesto de fórmula (I)), y el cristal tipo I y su método de preparación. El cristal tipo I del compuesto de fórmula (I) obtenido en la presente invención tiene buena estabilidad de forma de cristal y estabilidad química, y el solvente de cristalización utilizado tiene baja toxicidad y bajo residuo, y puede utilizarse mejor en el tratamiento clínico. (ver Fórmula).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510280720 | 2015-05-27 | ||
| PCT/CN2016/083423 WO2016188444A1 (zh) | 2015-05-27 | 2016-05-26 | 一种尿酸转运蛋白抑制剂的钠盐及其结晶形式 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017014319A true MX2017014319A (es) | 2018-03-07 |
| MX379184B MX379184B (es) | 2025-03-10 |
Family
ID=57393793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017014319A MX379184B (es) | 2015-05-27 | 2016-05-26 | Sal sodica de inhibidor de transportador de acido urico y su forma cristalina. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10196361B2 (es) |
| EP (1) | EP3305768B1 (es) |
| JP (1) | JP6738350B2 (es) |
| KR (1) | KR20180006441A (es) |
| CN (1) | CN107001276B (es) |
| AU (1) | AU2016269359B2 (es) |
| BR (1) | BR112017022505A2 (es) |
| CA (1) | CA2984961C (es) |
| CY (1) | CY1123262T1 (es) |
| DK (1) | DK3305768T3 (es) |
| ES (1) | ES2811325T3 (es) |
| HR (1) | HRP20201178T1 (es) |
| HU (1) | HUE051640T2 (es) |
| LT (1) | LT3305768T (es) |
| MX (1) | MX379184B (es) |
| PL (1) | PL3305768T3 (es) |
| PT (1) | PT3305768T (es) |
| RS (1) | RS60749B1 (es) |
| RU (1) | RU2719484C2 (es) |
| SI (1) | SI3305768T1 (es) |
| SM (1) | SMT202000421T1 (es) |
| WO (1) | WO2016188444A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3305768T (pt) * | 2015-05-27 | 2020-08-03 | Jiangsu Hengrui Medicine Co | Sal de sódio de um inibidor do transportador do ácido úrico e forma cristalina do mesmo |
| CN108201529B (zh) * | 2016-12-16 | 2021-10-08 | 江苏恒瑞医药股份有限公司 | 一种含有尿酸转运蛋白抑制剂的药物组合物及其制备方法 |
| CN110467571B (zh) * | 2018-05-11 | 2021-02-26 | 江苏恒瑞医药股份有限公司 | 一种制备环烷基甲酸类衍生物或其可药用盐的方法 |
| WO2025072489A2 (en) | 2023-09-27 | 2025-04-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Analogues of n-lactoyl-phenylalanine, methods of synthesis, and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA04250253B1 (ar) * | 2003-08-21 | 2009-11-10 | استرازينيكا ايه بي | احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن |
| AR051780A1 (es) * | 2004-11-29 | 2007-02-07 | Japan Tobacco Inc | Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos |
| EP2998296B1 (en) * | 2013-05-13 | 2018-03-14 | Shanghai Hengrui Pharmaceutical Co. Ltd. | Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof |
| PT3305768T (pt) * | 2015-05-27 | 2020-08-03 | Jiangsu Hengrui Medicine Co | Sal de sódio de um inibidor do transportador do ácido úrico e forma cristalina do mesmo |
-
2016
- 2016-05-26 PT PT167993310T patent/PT3305768T/pt unknown
- 2016-05-26 LT LTEP16799331.0T patent/LT3305768T/lt unknown
- 2016-05-26 MX MX2017014319A patent/MX379184B/es unknown
- 2016-05-26 CA CA2984961A patent/CA2984961C/en active Active
- 2016-05-26 SM SM20200421T patent/SMT202000421T1/it unknown
- 2016-05-26 KR KR1020177035949A patent/KR20180006441A/ko not_active Ceased
- 2016-05-26 RS RS20200924A patent/RS60749B1/sr unknown
- 2016-05-26 CN CN201680003846.8A patent/CN107001276B/zh active Active
- 2016-05-26 JP JP2017555478A patent/JP6738350B2/ja not_active Expired - Fee Related
- 2016-05-26 RU RU2017142996A patent/RU2719484C2/ru active
- 2016-05-26 US US15/574,328 patent/US10196361B2/en active Active
- 2016-05-26 HR HRP20201178TT patent/HRP20201178T1/hr unknown
- 2016-05-26 HU HUE16799331A patent/HUE051640T2/hu unknown
- 2016-05-26 BR BR112017022505-0A patent/BR112017022505A2/pt not_active Application Discontinuation
- 2016-05-26 PL PL16799331T patent/PL3305768T3/pl unknown
- 2016-05-26 AU AU2016269359A patent/AU2016269359B2/en not_active Ceased
- 2016-05-26 WO PCT/CN2016/083423 patent/WO2016188444A1/zh not_active Ceased
- 2016-05-26 ES ES16799331T patent/ES2811325T3/es active Active
- 2016-05-26 SI SI201630871T patent/SI3305768T1/sl unknown
- 2016-05-26 DK DK16799331.0T patent/DK3305768T3/da active
- 2016-05-26 EP EP16799331.0A patent/EP3305768B1/en active Active
-
2018
- 2018-10-11 US US16/157,696 patent/US10358424B2/en active Active
-
2020
- 2020-08-04 CY CY20201100720T patent/CY1123262T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10196361B2 (en) | 2019-02-05 |
| ES2811325T3 (es) | 2021-03-11 |
| CA2984961A1 (en) | 2016-12-01 |
| AU2016269359A1 (en) | 2017-11-23 |
| HRP20201178T1 (hr) | 2020-11-13 |
| CN107001276A (zh) | 2017-08-01 |
| BR112017022505A2 (pt) | 2018-07-17 |
| US20190040015A1 (en) | 2019-02-07 |
| SMT202000421T1 (it) | 2020-09-10 |
| HUE051640T2 (hu) | 2021-03-01 |
| DK3305768T3 (da) | 2020-08-10 |
| AU2016269359B2 (en) | 2020-02-06 |
| MX379184B (es) | 2025-03-10 |
| RU2017142996A3 (es) | 2019-11-20 |
| CY1123262T1 (el) | 2021-12-31 |
| EP3305768B1 (en) | 2020-07-01 |
| JP2018515454A (ja) | 2018-06-14 |
| EP3305768A1 (en) | 2018-04-11 |
| CN107001276B (zh) | 2020-03-13 |
| SI3305768T1 (sl) | 2020-10-30 |
| WO2016188444A1 (zh) | 2016-12-01 |
| PT3305768T (pt) | 2020-08-03 |
| US20180134663A1 (en) | 2018-05-17 |
| PL3305768T3 (pl) | 2020-12-28 |
| US10358424B2 (en) | 2019-07-23 |
| EP3305768A4 (en) | 2019-02-13 |
| JP6738350B2 (ja) | 2020-08-12 |
| RS60749B1 (sr) | 2020-10-30 |
| CA2984961C (en) | 2023-08-01 |
| KR20180006441A (ko) | 2018-01-17 |
| RU2017142996A (ru) | 2019-06-27 |
| LT3305768T (lt) | 2020-08-25 |
| RU2719484C2 (ru) | 2020-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR102014006322B8 (pt) | 4-amino-6-picolinatos(heterocílicos) e 6-amino-2-pirimidina-(heterocíclica)-4-carboxilatos, e processo para controle de vegetação indesejada | |
| EA201591891A1 (ru) | Пептидное соединение | |
| ECSP16076566A (es) | Compuestos de heteroarilo o arilo biciclicos fusionados y su aplicación a inhibidores de irak4 | |
| AR098110A1 (es) | Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina | |
| EA201492285A1 (ru) | Соединения n-алкилтриазола в качестве антагонистов лизофосфатидной кислоты (lpar) | |
| EA201490747A1 (ru) | 1-арилкарбонил-4-оксипиперидиновые соединения, полезные для лечения нейродегенеративных заболеваний | |
| EA201400735A1 (ru) | Производные альфа-амино бороновой кислоты, селективные ингибиторы иммунопротеасомы | |
| UY35683A (es) | Polimorfo de inhibidores de tirosina quinasa de bazo (syk) | |
| CY1123262T1 (el) | Αναστολεας metaφopea aλatoς natpioy oypikoy oξeoς kai kpyσtaλλikh mopφh aytoy | |
| AR133154A2 (es) | Proceso de producción de cristales de derivado de diazabiciclooctano y preparación liofilizada estable | |
| MX2017011392A (es) | P-toluensulfonato para inhibidor de mek cinasa, y su forma de cristal y su metodo de preparacion. | |
| WO2014128545A3 (en) | An improved process for the preparation of dolutegravir | |
| MX2020010384A (es) | Proceso para la fabricacion de medicamentos. | |
| BR112015029348A2 (pt) | inibidores da bace | |
| AR110119A1 (es) | Proceso para la purificación de pirazolpiridazinas | |
| EA201691983A1 (ru) | Пиридин-2-амиды, пригодные в качестве агонистов cb2 | |
| UY37421A (es) | Método para producir la forma cristalina de modificación a de calcobutrol | |
| MX394399B (es) | Inhibidor de urat1 para promover la excresion de acido urico. | |
| MX2017009270A (es) | Hidroxietil sulfonato de inhibidor de proteina cinasa dependiente de ciclina, su forma cristalina y su metodo de preparacion. | |
| MX2017007573A (es) | Composicion acuosa novedosa. | |
| EA201790098A1 (ru) | Гербицидно действующие амиды арилкарбоновых кислот | |
| EA201892020A1 (ru) | Индольные производные и их применение в качестве ингибиторов протеинкиназы | |
| EA201790522A1 (ru) | Соль производного цефалоспорина, ее кристаллическое твердое вещество и способ ее получения | |
| TW201613944A (en) | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | |
| BR112017005454A2 (pt) | composto de l-prolina do inibidor 2 do cotransportador de sódio-glicose, e mono-hidrato e cristal do composto de l-prolina |